Wilson Sonsini Goodrich & Rosati is advising ARCA biopharma, Inc. on the transaction, while Gibson, Dunn & Crutcher is advising Oruka Therapeutics and Cooley is advising...
ARCA Biopharma’s Merger with Oruka Therapeutics
Foresight Diagnostics’ $58.75 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
Electra’s $85 Million Fundraise
Wilson Sonsini Goodrich & Rosati advised Electra on the deal. Electra, a green iron company, announced it raised $85 million to produce Low-Temperature Iron (LTI) from...